A Strategic Overview

In the evolving landscape of global healthcare regulations, medical device manufacturers targeting both the United Kingdom and the European Union must navigate two distinct conformity frameworks: UKCA (UK Conformity Assessed) and CE (Conformité Européenne). Since the UK’s exit from the European Union, the transition from a unified marking system to a dual-regulatory environment has introduced significant complexities in compliance and market access.

Understanding the Geographical Jurisdiction

The most fundamental difference lies in where these marks are legally recognized:

• CE Marking: Remains mandatory for products placed on the market in the 27 EU Member States and the European Economic Area (EEA).
• UKCA Marking: Is the specific product marking required for goods being placed on the market in Great Britain (England, Scotland, and Wales).
• Northern Ireland: Under the Windsor Framework, Northern Ireland continues to align with EU rules, requiring the CE mark or the UKNI mark.

Regulatory Authorities and Compliance Standards

While both markings demonstrate that a product meets essential health, safety, and environmental standards, the governing bodies differ:

• Conformity Assessment Bodies: CE marking requires assessment by EU Notified Bodies. Conversely, UKCA marking must be carried out by UK Approved Bodies.
• Legislative Framework: CE marking is governed by EU Regulations such as the MDR (2017/745) and IVDR (2017/746). The UKCA mark is governed by the UK Medical Devices Regulations 2002 (as amended).

Read the Full blog, to know more : https://resource.ddregpharma.com/blogs/difference-between-ukca-and-ce-marking/

Follow us on :

Facebook: https://www.facebook.com/DDReg/

LinkedIn : https://www.linkedin.com/company/ddregpharma

Twitter: https://x.com/DDRegPharma

Instagram : https://www.instagram.com/ddregpharma